Serum gets nod for Novavax trial in 7-11 age group

(MENAFN - NewsBytes) The Serum Institute of India (SII) has received the approval to conduct trials of the Novavax COVID-19 vaccine in children aged between seven and 11 years. The Drugs Controller General of India (DCGI) on Tuesday gave the green signal...